Summary
IDEXX LABORATORIES INC /DE (IDXX) filed an 8-K on November 11, 2024, reporting a significant change in its Board of Directors. Jonathan W. Ayers, a long-serving former executive and director, resigned from the Board and its finance committee effective November 8, 2024. The company stated that Mr. Ayers's departure was not due to any disagreements regarding company operations, policies, or practices. Mr. Ayers had a substantial tenure with IDXX, having served as Chairman, President, and CEO from 2002 to 2019, and as a non-employee director until his recent resignation. The Board expressed gratitude for his over two decades of service and contributions. Following his resignation, the size of the Board has been reduced from eleven to ten directors. The filing also includes his resignation letter as an exhibit.
Key Highlights
- 1Jonathan W. Ayers, former Chairman, President, and CEO, has resigned from the Board of Directors.
- 2Mr. Ayers also stepped down from his position on the Board's finance committee.
- 3The resignation is effective November 8, 2024.
- 4The company has explicitly stated that Mr. Ayers's resignation is not due to any disagreements with the company.
- 5Mr. Ayers had a long and distinguished history with IDXX, serving in leadership roles for over two decades.
- 6The Board of Directors' size has been reduced from eleven to ten members as a result of this resignation.
- 7The filing includes Mr. Ayers's resignation letter as Exhibit 99.1.